Is Cephalexin 500 mg twice daily for 5 days an appropriate regimen for a skin infection?

Cephalexin 500mg BD for 5 Days is SUBOPTIMAL for Most Skin Infections

The standard dosing for cephalexin in skin and soft tissue infections is 500 mg four times daily (QID) for 7-10 days, not twice daily for 5 days. While twice-daily dosing has been studied and may be effective in select cases, the proposed 5-day duration is too short for most bacterial skin infections.

Recommended Dosing Based on Guidelines

Standard Regimen (Preferred)

According to IDSA guidelines, cephalexin should be dosed at 500 mg QID (four times daily) for skin infections 1, 2. The FDA-approved dosing confirms this: for skin and skin structure infections, the standard adult dose is 250 mg every 6 hours, with 500 mg every 12 hours reserved only for specific indications like streptococcal pharyngitis 3.

Duration of Therapy

• Minimum 7 days is recommended for most skin infections 2, 3
• 5 days may be adequate ONLY if there is documented clinical improvement by day 5 in uncomplicated cellulitis 4
• For streptococcal infections specifically, at least 10 days of therapy is required 3

When Twice-Daily Dosing May Be Acceptable

Research evidence suggests twice-daily cephalexin can be effective in certain scenarios:

• Higher doses are needed: Studies showing efficacy of BID dosing used 500mg-1000mg doses 5, 6, 7
• Uncomplicated infections only: Simple impetigo or minor cellulitis without systemic symptoms 8, 9
• NOT for severe infections: Any infection with systemic signs, immunocompromise, or deeper tissue involvement requires standard QID dosing 1, 2

Critical Pitfalls to Avoid

1. Underdosing risk: 500mg BID provides lower drug exposure than 500mg QID, potentially leading to treatment failure rates of 12-17% 10

2. Duration matters: The 5-day course is problematic because:

   • Most guidelines specify 7-14 days 2, 3
   • Streptococcal infections require ≥10 days to prevent complications 3
   • Early discontinuation risks recurrence

3. Wrong pathogen coverage: If MRSA is suspected (purulent drainage, injection drug use, penetrating trauma), cephalexin is inappropriate regardless of dosing 11, 2, 4

Recommended Approach

For typical non-purulent cellulitis or impetigo:

• Cephalexin 500 mg QID × 7-10 days 1, 2, 3
• Alternative: Cephalexin 500 mg BID × 7-10 days may be considered for mild infections to improve compliance 5, 7, though this is off-label

If considering the proposed regimen (500mg BID × 5 days):

• Only acceptable for very mild, uncomplicated infections
• Must reassess at day 5 - if not completely resolved, extend to 7-10 days
• Consider increasing to 1000mg BID if using twice-daily dosing 10

Red flags requiring different management:

• Purulent drainage → consider MRSA coverage (TMP-SMX, doxycycline, clindamycin) 11, 2
• Systemic symptoms → may need IV therapy or MRSA coverage 2
• Facial involvement or severe edema → may need higher doses or IV therapy 1
• Immunocompromised patients → broader coverage needed 2